)
Visual
test
Synektik
Synektik (SNTP) investor relations material
Synektik Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary12 Feb, 2026
Executive summary
Achieved 12% year-over-year growth in total revenue to 228.0 million PLN for Q1 FY2025, with strong performance in medical equipment, IT solutions, and radio-pharmaceuticals segments.
EBITDA from continuing operations rose 18% year-over-year to 59.8 million PLN, and net profit from continuing operations increased 18% to 43.1 million PLN.
Significant progress in recurring revenue, up 34% year-over-year to 91.2 million PLN, driven by service contracts and consumables.
Strategic expansion in robotic surgery and IT, including new distribution agreements and market entry plans for Ukraine.
Financial highlights
Revenue: 227.98 million PLN (Q1 FY2025) vs. 203.13 million PLN (Q1 FY2024), up 12%.
EBITDA (continuing): 59.8 million PLN, up 18% year-over-year.
Net profit (continuing): 43.1 million PLN, up 18% year-over-year.
Radio-pharmaceuticals segment revenue: 13.9 million PLN, up 15% year-over-year.
Recurring revenue (last 12 months): 334.3 million PLN, up 52% year-over-year.
Outlook and guidance
Management expects continued growth in medical equipment and IT services, supported by public healthcare investments and EU funds.
Expansion in robotic surgery, including new markets (Ukraine), and introduction of new products like the Edison system.
Ongoing development of the cardiomarker project and clinical research activities.
Spin-off's impact on Group's future profitability?
New markets and products: growth strategy
Cash flow and capital allocation strategy
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Synektik
- 9% revenue growth, 24% EBITDA increase, and strategic R&D spin-off highlight strong results.SNTP
Q4 202518 Nov 2025 - Revenue and EBITDA soared on strong medical equipment and recurring sales, with robust outlook.SNTPQ2 202422 Sep 2025
- Revenue up 55% and net profit up 74% year-over-year, with strong growth in all key segments.SNTPQ3 202422 Sep 2025
- Revenue and profit surged on strong medical equipment and radio-pharma growth, with margin gains.SNTPQ4 202422 Sep 2025
- Recurring revenue and radio-pharmaceutical sales rose, while EBITDA margin improved.SNTPQ1 202522 Sep 2025
- EBITDA margin rose to 24.7% as recurring revenues grew, despite a 9% drop in sales.SNTPQ2 202522 Sep 2025
- Q3 revenue up 24% YoY, EBITDA up 31%, with R&D spin-off and robust recurring revenue growth.SNTPQ3 202522 Sep 2025
Next Synektik earnings date
Q2 202611 Jun, 2026
Synektik
Next Synektik earnings date
Q2 202611 Jun, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage